• SENSEX 74,113.11
    867.08 (+1.18%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • NSE
    1,795.00 1,878.00(%)
  • Tube Investments
    2,151.20 3,335.00(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,175.35 1,108.20(%)
  • Cholaman.Inv.&Fn
    1,615.80 1,952.00(%)
  • Birlasoft Ltd
    352.25 473.75(%)
  • Billionbrains
    193.00 227.00(%)
  • Bajaj Finance
    941.50 1,177.60(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • Adani Ports
    1,870.90 1,891.80(%)
  • HDFC Bank
    678.05 668.90(%)
  • Kotak Mah. Bank
    460.00 453.00(%)
  • M & M Fin. Serv.
    265.20 415.00(%)
  • Aditya Infotech
    3,888.05 1,301.10(%)
  • Acutaas Chemical
    4,031.85 3,977.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenotech Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Sun Pharma
  • BSE Code : 7341.0
  • ISIN : INE486F01012
37.80 -1 (-1.84%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    37.58

  • Today’s High

    38.89

  • Open

    38.58

  • Perv Close

    38.51

  • 52W Low

    33.55

  • 52W High

    54.14

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    230.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.59

  • Debt-Equity Ratio

    -1.84

  • AGM Date

    28-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    230.70

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    61.03

  • BV (₹)

    15.60

  • Sales( ₹ in Cr.)

    43.61

  • NP (in Cr.)

    -1.10

  • NP Var(%)

    -138.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    -0.20

  • Traded Value (₹ in Lakhs)

    230.70

  • 52 Week High

    54.14

  • 52 Week Low

    33.55

  • Price BSE

    38.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    230.70

  • P/C Ratio

    38.60

  • P/E Ratio

    -211.00

  • Price Vs.BV

    -0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 43.61 43.05 40.83 42.42 36.57 22.45
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.61 43.05 40.83 42.42 36.57 22.45
Other Income 2.31 3.47 1.00 1.08 0.63 0.41
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 45.92 46.52 41.83 43.50 37.20 22.86
EXPENDITURE :            
Raw Materials 0.00 0.84 0.00 0.06 0.00 0.03
Power and Fuel Cost 3.24 2.71 2.69 3.79 3.25 3.12
Employee Cost 15.53 12.38 9.46 7.88 7.10 6.49
Other Manufacturing Expenses 11.96 9.52 8.70 7.67 6.66 4.67
Selling and Administration Expenses 2.85 2.85 2.33 2.00 1.91 1.62
Miscellaneous Expenses 1.05 0.57 0.43 0.31 0.19 0.13
Employee Benefit Expenses 15.53 12.38 9.46 7.88 7.10 6.49
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 34.62 28.87 23.61 21.72 19.10 16.06
Operating Profit 11.30 17.65 18.23 21.79 18.09 6.79
Interest 0.00 0.00 0.00 0.11 1.22 1.55
Gross Profit 11.30 17.65 18.23 21.68 16.87 5.24
Depreciation 7.11 6.96 7.09 7.17 6.97 6.46
Profit Before Tax 4.19 10.69 11.14 14.51 9.90 -1.22
Current Tax 0.49 2.49 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.77 2.59 2.84 2.92 -12.27 0.00
Reported Net Profit -1.07 5.61 8.30 11.59 22.18 -1.22
Extraordinary Items 0.03 2.73 -0.03 0.03 0.00 0.00
Adjusted Net Profit -1.10 2.88 8.33 11.56 22.18 -1.22
Adjustment below Net Profit 0.06 -0.02 -0.03 0.04 0.06 -0.01
P & L Balance brought forward -174.44 -180.03 -188.30 -199.93 -222.17 -220.94
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -175.45 -174.44 -180.03 -188.30 -199.93 -222.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.18 0.92 1.36 1.90 3.63 -0.20
Earnings Per Share(Adj)-Unit Curr -0.18 0.92 1.36 1.90 3.63 -0.20
Book Value 15.59 15.75 14.84 13.48 11.57 7.93
Book Value(Adj)-Unit Curr 15.59 15.75 14.84 13.48 11.57 7.93

Shareholding Pattern

  • Promoter Group

    68.84%

  • Public Share Holding

    31.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 42,014,578 68.84 42,014,578 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,014,578 68.84 42,014,578 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 600,000 0.98 600,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,364 0.01 4,364 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 604,364 0.99 604,364 2
2] Non Institution
Bodies Corporate 2,654,479 4.35 2,654,479 56
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 195,783 0.32 188,315 117
Foreign Non Institution Other 692,791 1.14 0 1
Hindu Undivided Families 86,762 0.14 86,762 252
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,365,421 15.35 4,272,183 50
Individuals holding nominal share capital up to Rs. 1 lakh 5,416,289 8.87 5,374,297 9,479
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 101 0.00 100 1
Sub Total 18,411,626 30.17 12,576,136 9,956
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,030,568 100.00 55,195,078 9,959

Company Background

Zenotech Laboratories LtdPharmaceuticals - Indian - Formulations

  • Zenotech Laboratories Ltd
  • BSE Code : 7341.0
  • ISIN : INE486F01012

  • Incorporation Year

    1989

  • Registered Office

    S No 250-252 Turkapally Villag
    Shameerpet Mandal RR District, Hyderabad,
    Telangana-500078

  • Telephone

    91-40-23480430/0435

  • FAX

    91-40-23480429

  • Chairman

  • Managing Director

  • Company Secretary

    Abdul Gafoor Mohammad

  • Auditor

    G S K A & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Zenotech Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenotech Lab. 37.80 45.92 43.61 -92.20 0.00
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77